Published in Law and Health Weekly, August 26th, 2006
Scientists writing in the journal Gynecologic Oncology noted, "Estimation of tumor volume by endovaginal magnetic resonance (MR) imaging is a better indicator of prognosis than FIGO stage in women with cervical cancer treated by standard modalities. However, the introduction of fertility conserving surgical techniques makes fresh demands upon imaging of these small tumors."
N.M. deSouza and colleagues at Hammersmith Hospital in England sought "to determine the sensitivity and specificity of endovaginal MRI in detecting small volume disease and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.